MDTC yields 3816.79% · JNJ yields 2.13%● Live data
📍 MDTC pulled ahead of the other in Year 1
Combined, MDTC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MDTC + JNJ for your $10,000?
Media Technologies, Inc., a full service paper converting company, manufactures and sells custom folding cartons primarily in the United States. The company provides die-cut header cards, clam shell inserts, chipboard slip sheets, and chipboard boxes. It offers solid bleached sulfate for use in cosmetic and pharmaceutical, ice cream, bakery and other food, and additional high-end packaging applications; gypsum used to convert brick divider sheets; and folding cartons for various retail packaging requirements, including cosmetics, candies, dog treats, frozen food and hardware products, pharmaceuticals, and textiles. The company also provides engineering plotter rolls; clay coated news back CCNB for various uses, such as color-printed folding cartons; and chipboards for various packaging and art applications, as well as wide format ink jet media and custom folders. In addition, it converts a range of premium paper stocks and packaging solutions. The company was formerly known as Town and Country Appraisal Service, Inc. and changed its name to Media Technologies, Inc. in June 2010. Media Technologies, Inc. was founded in 1976 and is based in Oklahoma City, Oklahoma.
Full MDTC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.